Although more participants in the iECG group were prescribed anticoagulant therapy, this difference did not reach statistical significance ( Table 2 ).
← all excerpts
Incident atrial fibrillation and adverse clinical outcomes during extended follow-up of participants recruited to the remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study.
1
—
—